• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

非晶态氟芬那酸和一种具有已解决结构的多晶型化合物的新记录。

Nonamorphism in flufenamic acid and a new record for a polymorphic compound with solved structures.

机构信息

Department of Chemistry and the Macromolecular Science and Engineering Program, University of Michigan-Ann Arbor, 930 North University Avenue, Ann Arbor, Michigan 48109-1055, USA.

出版信息

J Am Chem Soc. 2012 Jun 20;134(24):9872-5. doi: 10.1021/ja302601f. Epub 2012 Jun 12.

DOI:10.1021/ja302601f
PMID:22690822
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3634867/
Abstract

The unprecedented polymorphism of the non-steroidal anti-inflammatory drug (NSAID) flufenamic acid (FFA) is described here. Nine polymorphs were accessed through the use of polymer-induced heteronucleation (PIHn) and solid-solid transformation at low temperature. Structural elucidation of six of these forms, in addition to the two previously known forms, makes FFA indisputably octamorphic. Although the structure of at least one other form of FFA remains elusive, the occurrence of most of these polymorphs under one crystallization condition through PIHn illustrates that a fine interplay exists among the kinetic factors that lead to phase selection in this NSAID.

摘要

本文描述了非甾体抗炎药(NSAID)氟芬那酸(FFA)前所未有的多晶型现象。通过使用聚合物诱导异核结晶(PIHn)和低温固-固转变,共获得了 9 种多晶型物。对其中 6 种形式的结构进行了阐明,此外还有之前已知的 2 种形式,这使得 FFA 无疑具有 8 种多晶型物。尽管至少还有一种 FFA 的多晶型物的结构仍然难以捉摸,但通过 PIHn 在一种结晶条件下出现了大多数这些多晶型物,这表明在这种 NSAID 中导致相选择的动力学因素之间存在着精细的相互作用。

相似文献

1
Nonamorphism in flufenamic acid and a new record for a polymorphic compound with solved structures.非晶态氟芬那酸和一种具有已解决结构的多晶型化合物的新记录。
J Am Chem Soc. 2012 Jun 20;134(24):9872-5. doi: 10.1021/ja302601f. Epub 2012 Jun 12.
2
Polymer-induced heteronucleation of tolfenamic acid: structural investigation of a pentamorph.聚合物诱导的托芬那酸异质成核:一种五变体的结构研究
J Am Chem Soc. 2009 Apr 8;131(13):4554-5. doi: 10.1021/ja806289a.
3
Stabilization of metastable flufenamic acid by inclusion of mefenamic acid: solid solution or epilayer?将甲芬那酸包合稳定亚稳型氟芬那酸:固溶体还是超晶格层?
J Pharm Sci. 2010 Sep;99(9):4013-22. doi: 10.1002/jps.22250.
4
The role of solid state properties on the dissolution performance of flufenamic acid.固体状态性质对 flufenamic 酸溶解性能的影响。
J Pharm Biomed Anal. 2020 Feb 20;180:113058. doi: 10.1016/j.jpba.2019.113058. Epub 2019 Dec 20.
5
Quantitative study of solid-state acid-base reactions between polymorphs of flufenamic acid and magnesium oxide using X-ray powder diffraction.采用 X 射线粉末衍射法对 flufenamic 酸多晶型物与氧化镁之间的固-酸碱反应进行定量研究。
J Pharm Biomed Anal. 2010 Mar 11;51(4):866-74. doi: 10.1016/j.jpba.2009.09.021. Epub 2009 Oct 14.
6
Crystal quality and physical reactivity in the case of flufenamic acid (FFA).氟芬那酸(FFA)的晶体质量和物理反应性。
J Pharm Sci. 2010 Sep;99(9):3839-48. doi: 10.1002/jps.22221.
7
Stimulatory Effects of Soluplus® on Flufenamic Acid β-Cyclodextrin Supramolecular Complex: Physicochemical Characterization and Pre-clinical Anti-inflammatory Assessment.Soluplus® 对氟芬那酸 β-环糊精超分子复合物的刺激作用:物理化学特性表征和临床前抗炎评估。
AAPS PharmSciTech. 2020 May 19;21(5):145. doi: 10.1208/s12249-020-01684-2.
8
Flufenamic acid as an ion channel modulator.氟芬那酸作为一种离子通道调节剂。
Pharmacol Ther. 2013 May;138(2):272-84. doi: 10.1016/j.pharmthera.2013.01.012. Epub 2013 Jan 25.
9
Thermodynamic properties of flufenamic and niflumic acids--specific and non-specific interactions in solution and in crystal lattices, mechanism of solvation, partitioning and distribution.氟芬那酸和尼氟酸的热力学性质——溶液和晶格中的特异性与非特异性相互作用、溶剂化机制、分配与分布
J Pharm Biomed Anal. 2007 Nov 30;45(4):679-87. doi: 10.1016/j.jpba.2007.01.039. Epub 2007 Feb 1.
10
A [24-MC-6] zinc metallacoronate with a nonsteroidal antiinflammatory drug as the constructing ligand.一种[24-MC-6]锌金属冠醚配合物,以非甾体抗炎药物作为构建配体。
Inorg Chem. 2012 Jul 16;51(14):7460-2. doi: 10.1021/ic3010757. Epub 2012 Jul 3.

引用本文的文献

1
From Molecular Interactions to Solubility in Deep Eutectic Solvents: Exploring Flufenamic Acid in Choline-Chloride- and Menthol-Based Systems.从分子相互作用到在深共晶溶剂中的溶解度:探索氟芬那酸在氯化胆碱和薄荷醇基体系中的情况
Molecules. 2025 Aug 20;30(16):3434. doi: 10.3390/molecules30163434.
2
One Size Fits All? Development of the CPOSS209 Data Set of Experimental and Hypothetical Polymorphs for Testing Computational Modeling Methods.一刀切?用于测试计算建模方法的CPOSS209实验性和假设性多晶型数据集的开发。
Cryst Growth Des. 2025 Apr 28;25(9):3186-3209. doi: 10.1021/acs.cgd.5c00255. eCollection 2025 May 7.
3
Polymorphic ROYalty: The 14th ROY Polymorph Discovered via High-Throughput Crystallization.多态性“皇族”:通过高通量结晶发现的第14种ROY多晶型物
J Am Chem Soc. 2025 Apr 9;147(14):11949-11954. doi: 10.1021/jacs.4c17826. Epub 2025 Mar 25.
4
3D Electron Diffraction Structure of an Organic Semiconductor Reveals Conformational Polymorphism.一种有机半导体的3D电子衍射结构揭示了构象多态性。
J Am Chem Soc. 2025 Feb 19;147(7):5669-5678. doi: 10.1021/jacs.4c12734. Epub 2025 Feb 6.
5
Preparation of intrinsically fragile bent crystals.本征易碎弯曲晶体的制备。
Chem Sci. 2024 Jul 11;15(31):12258-12263. doi: 10.1039/d4sc02918f. eCollection 2024 Aug 7.
6
Unveiling a Novel Solvatomorphism of Anti-inflammatory Flufenamic Acid: X-ray Structure, Quantum Chemical, and Studies.揭示抗炎药氟芬那酸的一种新型溶剂同构现象:X射线结构、量子化学及研究
ACS Omega. 2024 May 3;9(19):20753-20772. doi: 10.1021/acsomega.3c07520. eCollection 2024 May 14.
7
First-Principles Models of Polymorphism of Pharmaceuticals: Maximizing the Accuracy-to-Cost Ratio.药物多晶型的第一性原理模型:最大化成本效益比。
J Chem Theory Comput. 2024 Apr 9;20(7):2858-2870. doi: 10.1021/acs.jctc.4c00099. Epub 2024 Mar 26.
8
Polymorphism in Solid Dispersions.固体分散体中的多晶型现象。
Cryst Growth Des. 2020 Feb 5;20(2):713-722. doi: 10.1021/acs.cgd.9b01138. Epub 2019 Dec 17.
9
3-Methyl-2-(4-methyl-phen-oxy)benzoic acid.
IUCrdata. 2023 Jul 14;8(Pt 7):x230600. doi: 10.1107/S2414314623006004. eCollection 2023 Jul.
10
Polymorphic transitions in flufenamic acid-trehalose composites.氟芬那酸-海藻糖复合物中的多晶型转变
Int J Pharm X. 2023 Jul 23;6:100200. doi: 10.1016/j.ijpx.2023.100200. eCollection 2023 Dec 15.

本文引用的文献

1
Crystal polymorphism in a carbamazepine derivative: oxcarbazepine.卡马西平衍生物:奥卡西平的晶体多态性。
J Pharm Sci. 2010 Feb;99(2):794-803. doi: 10.1002/jps.21873.
2
Investigation of a Privileged Polymorphic Motif: a Dimeric ROY Derivative.一种特殊多态性基序的研究:一种二聚体ROY衍生物。
Cryst Growth Des. 2008;8(1):136-139. doi: 10.1021/cg700921w.
3
Polymer-induced heteronucleation of tolfenamic acid: structural investigation of a pentamorph.聚合物诱导的托芬那酸异质成核:一种五变体的结构研究
J Am Chem Soc. 2009 Apr 8;131(13):4554-5. doi: 10.1021/ja806289a.
4
Two polymorphs of chlorpropamide: the delta-form and the high-temperature epsilon-form.氯磺丙脲的两种多晶型物:δ型和高温ε型。
Acta Crystallogr C. 2008 Dec;64(Pt 12):o623-5. doi: 10.1107/S0108270108034550. Epub 2008 Nov 8.
5
Conformational polymorphism in aripiprazole: Preparation, stability and structure of five modifications.阿立哌唑的构象多晶型:五种变体的制备、稳定性和结构
J Pharm Sci. 2009 Jun;98(6):2010-26. doi: 10.1002/jps.21574.
6
A new gamma-polymorph of chlorpropamide: 4-chloro-N-(propylaminocarbonyl)benzenesulfonamide.氯磺丙脲的一种新的γ-多晶型物:4-氯-N-(丙基氨基甲酰基)苯磺酰胺。
Acta Crystallogr C. 2007 Jun;63(Pt 6):o355-7. doi: 10.1107/S010827010701952X. Epub 2007 May 11.
7
Abundant polymorphism in a system with multiple hydrogen-bonding opportunities: oxalyl dihydrazide.具有多个氢键形成机会的体系中的丰富多态性:草酰二肼。
J Am Chem Soc. 2006 Jul 5;128(26):8441-52. doi: 10.1021/ja0573155.
8
Cross-nucleation between ROY polymorphs.ROY多晶型物之间的交叉成核。
J Am Chem Soc. 2005 Dec 14;127(49):17439-44. doi: 10.1021/ja056072d.
9
New polymorphs of ROY and new record for coexisting polymorphs of solved structures.ROY的新多晶型物以及已解析结构中共存多晶型物的新记录。
J Am Chem Soc. 2005 Jul 13;127(27):9881-5. doi: 10.1021/ja052098t.
10
Crystalline polymorph selection and discovery with polymer heteronuclei.利用聚合物异质核进行晶体多晶型的选择与发现。
J Am Chem Soc. 2005 Apr 20;127(15):5512-7. doi: 10.1021/ja042561m.